SFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Haraguchi, Ryuma ^a   Kitazawa, Riko ^a,b   Mori, Kiyoshi ^c   Tachibana, Ryosuke ^a   Kiyonari, Hiroshi ^d   Imai, Yuuki ^a   Abe, Takaya ^d   Kitazawa, Sohei ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; SFRP4 PROTEIN, MOUSE;

ANIMAL; BONE REMODELING; CYTOLOGY; DISEASE MODEL; GENE KNOCK-IN; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; TRABECULAR BONE; WNT SIGNALING;

ANIMALS; BONE REMODELING; CANCELLOUS BONE; DISEASE MODELS, ANIMAL; GENE KNOCK-IN TECHNIQUES; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PROTO-ONCOGENE PROTEINS; WNT SIGNALING PATHWAY;

EID: 84964957711     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25198     Document Type: Article

References (57)

1. Ducy, P., Schinke, T. & Karsenty, G. The osteoblast: A sophisticated fibroblast under central surveillance. Science 289, 1501-1504 (2000).
2. Teitelbaum, S. L. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
3. Yamaguchi, A., Komori, T. & Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr rev. 21, 393-411, doi: 10.1210/edrv.21.4.0403 (2000).
4. Lian, J. B. et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metabolic Disord 7, 1-16, doi: 10.1007/s11154-006-9001-5 (2006).
5. Nishimura, R. et al. Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab. 26, 203-212, doi: 10.1007/s00774-007-0824-2 (2008).
6. Hu, H. et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132, 49-60, doi: 10.1242/dev.01564 (2005).
7. Babij, P. et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res. 18, 960-974, doi: 10.1359/jbmr.2003.18.6.960 (2003).
8. Boyden, L. M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 346, 1513-1521, doi: 10.1056/NEJMoa013444 (2002).
9. Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523 (2001).
10. Little, R. D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 70, 11-19, doi: 10.1086/338450 (2002).
11. Van Wesenbeeck, L. et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet. 72, 763-771, doi: 10.1086/368277 (2003).
12. Gordon, M. D. & Nusse, R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 281, 22429-22433, doi: 10.1074/jbc.R600015200 (2006).
13. Kawano, Y. & Kypta, R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 116, 2627-2634, doi: 10.1242/jcs.00623 (2003).
14. Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E. & Lopez-Rios, J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci. 121, 737-746, doi: 10.1242/jcs.026096 (2008).
15. Belaya, Z. E. et al. Serum extracellular secreted antagonists of the canonical Wnt/beta-catenin signaling pathway in patients with Cushing's syndrome. Osteoporos Int. 24, 2191-2199, doi: 10.1007/s00198-013-2268-y (2013).
16. Cho, H. Y. et al. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis. Bone 47, 263-271, doi: 10.1016/j. bone.2010.05.010 (2010).
17. Garufi, G., Seyhan, A. A. & Pasarica, M. Elevated secreted frizzled-related protein 4 in obesity: A potential role in adipose tissue dysfunction. Obesity 23, 24-27, doi: 10.1002/oby.20915 (2015).
18. Marsit, C. J., McClean, M. D., Furniss, C. S. & Kelsey, K. T. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer. 119, 1761-1766, doi: 10.1002/ijc.22051 (2006).
19. Qi, J., Zhu, Y. Q., Luo, J. & Tao, W. H. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol. 12, 7113-7117 (2006).
20. Mori, K. et al. Diabetic osteopenia by decreased beta-catenin signaling is partly induced by epigenetic derepression of sFRP-4 gene. PLos one 9, e102797, doi: 10.1371/journal.pone.0102797 (2014).
21. Nakanishi, R. et al. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. J Bone Miner Res. 23, 271-277, doi: 10.1359/jbmr.071007 (2008).
22. Leimeister, C., Bach, A. & Gessler, M. Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family. Mech Dev. 75, 29-42 (1998).
23. Witte, F., Dokas, J., Neuendorf, F., Mundlos, S. & Stricker, S. Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation. Gene Expr Patterns. 9, 215-223, doi: 10.1016/j. gep.2008.12.009 (2009).
24. Jho, E. H. et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 22, 1172-1183 (2002).
25. Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823, doi: 10.1016/j.cell.2007.07.025 (2007).
26. Liu, Y. et al. Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma. PLos one 8, e71318, doi: 10.1371/journal.pone.0071318 (2013).
27. Mizoguchi, T. et al. Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Dev Cell 29, 340-349, doi: 10.1016/j.devcel.2014.03.013 (2014).
28. Rawadi, G., Vayssiere, B., Dunn, F., Baron, R. & Roman-Roman, S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 18, 1842-1853, doi: 10.1359/jbmr.2003.18.10.1842 (2003).
29. Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 19, 179-192, doi: 10.1038/nm.3074 (2013).
30. Glass, D. A. 2nd & Karsenty, G. In vivo analysis of Wnt signaling in bone. Endocrinology 148, 2630-2634, doi: 10.1210/en.2006-1372 (2007).
31. Herr, P., Hausmann, G. & Basler, K. WNT secretion and signalling in human disease. Trends Mol Med. 18, 483-493, doi: 10.1016/j. molmed.2012.06.008 (2012).
32. Albers, J. et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol. 200, 537-549, doi: 10.1083/jcb.201207142 (2013).
33. Qiang, Y. W. et al. Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma. Br J Haematol. 148, 726-738, doi: 10.1111/j.1365-2141.2009.08009.x (2010).
34. Nakanishi, R. et al. Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice. J Bone Miner Res. 21, 1713-1721, doi: 10.1359/jbmr.060719 (2006).
35. Beamer, W. G., Donahue, L. R., Rosen, C. J. & Baylink, D. J. Genetic variability in adult bone density among inbred strains of mice. Bone 18, 397-403 (1996).
36. Matsushita, M. et al. Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol. 125, 276-283 (1986).
37. Haraguchi, R. et al. Molecular analysis of coordinated bladder and urogenital organ formation by Hedgehog signaling. Development 134, 525-533, doi: 10.1242/dev.02736 (2007).
38. Tan, S. H. et al. Wnts produced by Osterix-expressing osteolineage cells regulate their proliferation and differentiation. Proc Natl Acad Sci USA 111, E5262-5271, doi: 10.1073/pnas.1420463111 (2014).
39. Moverare-Skrtic, S. et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med. 20, 1279-1288, doi: 10.1038/nm.3654 (2014).
40. Gaur, T. et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 280, 33132-33140, doi: 10.1074/jbc.M500608200 (2005).
41. Bennett, C. N. et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102, 3324-3329, doi: 10.1073/pnas.0408742102 (2005).
42. Bodine, P. V. et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 18, 1222-1237, doi: 10.1210/me.2003-0498 (2004).
43. Lee, H. X., Ambrosio, A. L., Reversade, B. & De Robertis, E. M. Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell 124, 147-159, doi: 10.1016/j.cell.2005.12.018 (2006).
44. Hausler, K. D. et al. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res. 19, 1873-1881, doi: 10.1359/JBMR.040807 (2004).
45. Lee, J. L., Lin, C. T., Chueh, L. L. & Chang, C. J. Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: A possible mechanism of mammary tumorigenesis. J Biol Chem. 279, 14602-14609, doi: 10.1074/jbc.M309008200 (2004).
46. Phan, T. C., Xu, J. & Zheng, M. H. Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol. 19, 1325-1344 (2004).
47. Sun, S. Bone disease drug discovery: examining the interactions between osteoblast and osteoclast. Expert Opin Ther Targets 12, 239-251, doi: 10.1517/14728222.12.2.239 (2008).
48. Haraguchi, R. et al. The hedgehog signal induced modulation of bone morphogenetic protein signaling: an essential signaling relay for urinary tract morphogenesis. PLos one 7, e42245, doi: 10.1371/journal.pone.0042245 (2012).
49. Nakagawa, M. et al. Efficient Genetic Analysis of Microdissected Samples by Agarose-Bead Method: Alterations of beta-Catenin Gene in Fundic Gland Polyp and Heterotopic Gastric Mucosa of Duodenum. Acta Histochem Cytochem. 46, 19-24, doi: 10.1267/ahc.12022 (2013).
50. Haraguchi, R., Kitazawa, R. & Kitazawa, S. Epigenetic regulation of Tbx18 gene expression during endochondral bone formation. Cell Tissue Res. 359, 503-512, doi: 10.1007/s00441-014-2028-0 (2015).
51. Dominici, M. et al. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114, 2333-2343, doi: 10.1182/blood-2008-10-183459 (2009).
52. Lomashvili, K. A., Narisawa, S., Millan, J. L. & O'Neill, W. C. Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int. 85, 1351-1356, doi: 10.1038/ki.2013.521 (2014).
53. Gauger, K. J., Shimono, A., Crisi, G. M. & Schneider, S. S. Loss of SFRP1 promotes ductal branching in the murine mammary gland. BMC Dev Biol. 12, 25, doi: 10.1186/1471-213X-12-25 (2012).
54. Amano, K., Densmore, M. J. & Lanske, B. Conditional Deletion of Indian Hedgehog in Limb Mesenchyme Results in Complete Loss of Growth Plate Formation But Allows Mature Osteoblast Differentiation. J Bone Miner Res. 30, 2262-2272, doi: 10.1002/jbmr.2582 (2015).
55. Hikita, A. et al. Analyses of bone modeling and remodeling using in vitro reconstitution system with two-photon microscopy. Bone 76, 5-17, doi: 10.1016/j.bone.2015.02.030 (2015).
56. Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 25, 1468-1486, doi: 10.1002/jbmr.141 (2010).
57. Kondoh, S. et al. Estrogen receptor alpha in osteocytes regulates trabecular bone formation in female mice. Bone 60, 68-77, doi: 10.1016/j.bone.2013.12.005 (2014).